| Wendy Monique Goodrich, PA C | |
|
2500 W A St Ste 101, Moscow, ID 83843 | |
| (208) 882-0540 | |
| Not Available |
| Full Name | Wendy Monique Goodrich |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 22 Years |
| Location | 2500 W A St Ste 101, Moscow, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255400388 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gritman Medical Center | Moscow, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gritman Medical Center Inc | 0941545784 | 18 |
News Archive
Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.
Scientists have known for years that the energy cost of walking and running is related primarily to the work done by muscles to lift and move the limbs.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Researchers centered at the University of Tsukuba and Kansai Medical University in Japan reveal matricellular protein Thrombospondin-1 (Thbs1) contributes to the development of aortic aneurysm in mice and humans.
Though March 31 is increasingly viewed as a somewhat soft deadline, it's come and gone amidst last-day technical troubles. In its wake, lots of analysis and speculation about where the ultimate tally - now estimated to have topped 7 million - may fall, as well as how many of those new enrollees were previously uninsured and how many will pay their premiums.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Monique Goodrich, PA C 623 S Main St Ste 1, Moscow, ID 83843-3042 Ph: (208) 882-2011 | Wendy Monique Goodrich, PA C 2500 W A St Ste 101, Moscow, ID 83843 Ph: (208) 882-0540 |
News Archive
Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.
Scientists have known for years that the energy cost of walking and running is related primarily to the work done by muscles to lift and move the limbs.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Researchers centered at the University of Tsukuba and Kansai Medical University in Japan reveal matricellular protein Thrombospondin-1 (Thbs1) contributes to the development of aortic aneurysm in mice and humans.
Though March 31 is increasingly viewed as a somewhat soft deadline, it's come and gone amidst last-day technical troubles. In its wake, lots of analysis and speculation about where the ultimate tally - now estimated to have topped 7 million - may fall, as well as how many of those new enrollees were previously uninsured and how many will pay their premiums.
› Verified 6 days ago